[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 60,226,056 Item 6: 0 Item 7: 64,626,784 Item 8: 0 Item 9: 64,626,784 Item 11: 11.656% Item 12: HC Cusip #929352920 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 64,626,784 Item 8: 0 Item 9: 64,626,784 Item 11: 11.656%]
[WuXi PharmaTech (Cayman) Inc. Form 6-K TABLE OF CONTENTS Page 3 4 2 WuXi PharmaTech (Cayman) Inc.]
[WuXi PharmaTech (Cayman) Inc. Form 6-K TABLE OF CONTENTS Page 3 4 2 WuXi PharmaTech (Cayman) Inc.]
[Form 6-K TABLE OF CONTENTS Page 3 4 2 WuXi PharmaTech (Cayman) Inc. Ge Li Chairman and CEO 3 ACQUISITION PROPOSEDYOUR VOTE IS VERY IMPORTANT Dear Shareholder: You are cordially invited to the upcoming special meeting of shareholders of Charles River to be held on [ in vivo [ [ []
[Form 6-K TABLE OF CONTENTS Page 3 4 2 WuXi PharmaTech (Cayman) Inc. Ge Li Chairman and CEO 3 ACQUISITION PROPOSEDYOUR VOTE IS VERY IMPORTANT Dear Shareholder: You are cordially invited to the upcoming special meeting of shareholders of Charles River to be held on [ in vivo [ [ []
[WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3 4 PRESS RELEASE DATED May 11, 2010 2]
[WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3 4 PRESS RELEASE DATED May 11, 2010 2]
[CUSIP No. 929352102 1]
[CUSIP No. 929352102 1]
[EXECUTION COPY VOTING AGREEMENT Acquiror Shareholder Shareholders AGREEMENT, dated as of April 26, 2010 between Charles River Laboratories International, Inc., a Delaware corporation ( Acquisition Agreemen Company Shares ADSs provided WHEREAS, in order to induce Acquiror to enter into an Agreement and Plan of Arrangement, dated as of the date hereof (the NOW, THEREFORE, the parties hereto agree as] []
